Related references
Note: Only part of the references are listed.Deacetylase inhibition promotes the generation and function of regulatory T cells
Ran Tao et al.
NATURE MEDICINE (2007)
Reversal of autoimmune disease in lupus-prone New Zealand black/New Zealand white mice by nom-nyeloablative transplantation of purified allogeneic hematopoietic stem cells
Stephanie Smith-Berdan et al.
BLOOD (2007)
Histone deacetylase inhibitors: molecular mechanisms of action
W. S. Xu et al.
ONCOGENE (2007)
TH-17 cells in the circle of immunity and autoimmunity
Estelle Bettelli et al.
NATURE IMMUNOLOGY (2007)
Elimination of insulitis and augmentation of islet β cell regeneration via induction of chimerism in overtly diabetic NOD mice
Chunyan Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function
Jennifer L. Brogdon et al.
BLOOD (2007)
Donor CD8+ T cells mediate graft-versus-leukemia activity without clinical signs of graft-versus-host disease in recipients conditioned with anti-CD3 monoclonal antibody
Chunyan Zhang et al.
JOURNAL OF IMMUNOLOGY (2007)
An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues
Ronjon Chakraverty et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1
Corinna Leng et al.
EXPERIMENTAL HEMATOLOGY (2006)
Opinion - Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells
C Dong
NATURE REVIEWS IMMUNOLOGY (2006)
NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs
ES Morris et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Treatment of severe autoimmune disease by stem-cell transplantation
M Sykes et al.
NATURE (2005)
Donor CD8+ T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb
YM Liang et al.
BLOOD (2005)
Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect
P Reddy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies
R Rodriguez et al.
BONE MARROW TRANSPLANTATION (2004)
The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses
JMA Moreira et al.
BMC CANCER (2003)
Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus
DF Zeng et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Histone deacetylases
PA Marks et al.
CURRENT OPINION IN PHARMACOLOGY (2003)
Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation
P Hoffmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Acute graft-versus-host disease does not require alloantigen expression on host epithelium
T Teshima et al.
NATURE MEDICINE (2002)
The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines
F Leoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Histone deacetylases and cancer: Causes and therapies
PA Marks et al.
NATURE REVIEWS CANCER (2001)
Cutting edge: A role for CD1 in the pathogenesis of lupus in NZB/NZW mice
D Zeng et al.
JOURNAL OF IMMUNOLOGY (2000)
Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment
T Werkele et al.
NATURE MEDICINE (2000)
Share Paper
